| Summary Of Earnings per Shares, basic and diluted | 
 Presented in the table below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share (“EPS”) calculations for the periods ended:  
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 
 | 
For the three months ended  | 
 | 
For the six  months ended | 
 
 | 
June 30, | 
 | 
June 30, | 
 
| (in 000’ USD, except share and per share amounts) | 
2022 | 
 | 
2021 | 
 | 
2022 | 
 | 
2021 | 
 
| Numerator: | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 
| Net loss attributable to the Company | 
$ | 
(11,141) | 
 | 
 | 
$ | 
(6,885) | 
 | 
 | 
$ | 
(22,048) | 
 | 
 | 
$ | 
(7,966) | 
 | 
 
| Less cumulative earnings to preferred shareholder | 
—  | 
 | 
 | 
(7,532) | 
 | 
 | 
—  | 
 | 
 | 
(14,925) | 
 | 
 
| Net loss attributable to common stockholders | 
(11,141) | 
 | 
 | 
(14,417) | 
 | 
 | 
(22,048) | 
 | 
 | 
(22,891) | 
 | 
 
| Denominator: | 
  | 
 | 
  | 
 | 
 | 
 | 
 | 
 
Weighted average common shares and warrants outstanding*  | 
  | 
 | 
  | 
 | 
 | 
 | 
 | 
 
| Basic (in number) | 
76,239,989  | 
 | 
 | 
31,647,131  | 
 | 
 | 
75,146,201  | 
 | 
 | 
31,647,131  | 
 | 
 
| Diluted (in number) | 
76,239,989  | 
 | 
 | 
31,647,131  | 
 | 
 | 
75,146,201  | 
 | 
 | 
31,647,131  | 
 | 
 
| Net loss per unit attributable to common stockholder | 
  | 
 | 
  | 
 | 
 | 
 | 
 | 
 
| Basic | 
$ | 
(0.15) | 
 | 
 | 
$ | 
(0.46) | 
 | 
 | 
$ | 
(0.29) | 
 | 
 | 
$ | 
(0.72) | 
 | 
 
| Diluted | 
$ | 
(0.15) | 
 | 
 | 
$ | 
(0.46) | 
 | 
 | 
$ | 
(0.29) | 
 | 
 | 
$ | 
(0.72) | 
 | 
 
  
*The KORE warrants have been treated as outstanding common shares in the weighted average common shares and warrants outstanding for the three months and six months ended June 30, 2021.
 
 | 
| Summary Of Diluted Shares Outstanding | 
 The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:  
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 
 | 
For the three months ended | 
 | 
For the six  months ended | 
 
| (Number of shares) | 
June 30, | 
 | 
June 30, | 
 
 | 
2022 | 
 | 
2021 | 
 | 
2022 | 
 | 
2021 | 
 
| Series C Convertible Preferred Stock | 
—  | 
 | 
 | 
2,520,368  | 
 | 
 | 
—  | 
 | 
 | 
2,520,368  | 
 | 
 
| Stock Options | 
—  | 
 | 
 | 
432,500  | 
 | 
 | 
—  | 
 | 
 | 
432,500  | 
 | 
 
| Common stock issued under the Backstop Agreement | 
9,600,031  | 
 | 
 | 
—  | 
 | 
 | 
9,600,031  | 
 | 
 | 
—  | 
 | 
 
| Restricted stock grants with only service conditions | 
3,441,651  | 
 | 
 | 
—  | 
 | 
 | 
3,275,885  | 
 | 
 | 
—  | 
 | 
 
  
 |